John Gordon

1.0k total citations · 1 hit paper
40 papers, 713 citations indexed

About

John Gordon is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Public Health, Environmental and Occupational Health. According to data from OpenAlex, John Gordon has authored 40 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 8 papers in Pharmaceutical Science and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in John Gordon's work include Assisted Reproductive Technology and Twin Pregnancy (7 papers), Pharmaceutical Economics and Policy (7 papers) and Drug Solubulity and Delivery Systems (6 papers). John Gordon is often cited by papers focused on Assisted Reproductive Technology and Twin Pregnancy (7 papers), Pharmaceutical Economics and Policy (7 papers) and Drug Solubulity and Delivery Systems (6 papers). John Gordon collaborates with scholars based in Canada, United States and Spain. John Gordon's co-authors include Jean Fergusson, Karen Moss, Philip Littman, AnnaT. Meadows, Alfredo García‐Arieta, Henrike Potthast, Michael DiMattina, M. Payson, Juan J. Torrado and R. Brooke Jeffrey and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and American Journal of Obstetrics and Gynecology.

In The Last Decade

John Gordon

39 papers receiving 668 citations

Hit Papers

DECLINES IN IQ SCORES AND COGNITIVE DYSFUNCTIONS IN CHILD... 1981 2026 1996 2011 1981 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Gordon Canada 11 277 236 157 154 110 40 713
Marjie Hard United States 14 220 0.8× 209 0.9× 28 0.2× 88 0.6× 33 0.3× 27 888
Jane Harness United States 12 83 0.3× 49 0.2× 43 0.3× 73 0.5× 31 0.3× 23 1.0k
Xiaochun Li United States 13 138 0.5× 85 0.4× 174 1.1× 325 2.1× 4 0.0× 55 1.2k
Kate Webber Australia 15 136 0.5× 88 0.4× 13 0.1× 136 0.9× 55 0.5× 47 669
Gary R. Shapiro United States 13 122 0.4× 179 0.8× 21 0.1× 109 0.7× 13 0.1× 23 666
Claude Schmitt United Kingdom 13 55 0.2× 57 0.2× 80 0.5× 64 0.4× 3 0.0× 31 772
Frédérique Rousseau France 14 22 0.1× 53 0.2× 17 0.1× 156 1.0× 92 0.8× 60 744
Meaghan Krohe United States 9 40 0.1× 37 0.2× 19 0.1× 59 0.4× 22 0.2× 19 336
Seo‐Young Park South Korea 12 78 0.3× 118 0.5× 14 0.1× 19 0.1× 34 0.3× 35 504
Marlies Peters Netherlands 17 199 0.7× 111 0.5× 19 0.1× 202 1.3× 8 0.1× 33 1.1k

Countries citing papers authored by John Gordon

Since Specialization
Citations

This map shows the geographic impact of John Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Gordon more than expected).

Fields of papers citing papers by John Gordon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Gordon. The network helps show where John Gordon may publish in the future.

Co-authorship network of co-authors of John Gordon

This figure shows the co-authorship network connecting the top 25 collaborators of John Gordon. A scholar is included among the top collaborators of John Gordon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Gordon. John Gordon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
García‐Arieta, Alfredo, et al.. (2023). Regulatory Requirements for the Development of Second-Entry Semisolid Topical Products in the European Union. Pharmaceutics. 15(2). 601–601. 5 indexed citations
2.
Cheung, Michael K., et al.. (2021). Electronic brachytherapy for treatment of non-melanoma skin cancers: clinical results and toxicities. Journal of Contemporary Brachytherapy. 13(5). 497–503. 3 indexed citations
3.
González‐Rojano, Esperanza, Leonor Laredo, John Gordon, et al.. (2020). Chiral bioanalytical methods in bioequivalence studies of intravenous vs. oral formulations of ibuprofen. Chirality. 32(9). 1169–1177. 4 indexed citations
4.
González‐Rojano, Esperanza, et al.. (2019). Sex-by-formulation interaction in bioequivalence trials with transdermal patches. European Journal of Clinical Pharmacology. 75(6). 801–808. 1 indexed citations
5.
Gordon, John, et al.. (2017). Global Harmonization of Comparator Products for Bioequivalence Studies. The AAPS Journal. 19(3). 603–606. 9 indexed citations
6.
Hullett, Craig R., et al.. (2016). Radiotherapeutic management of vestibular schwannomas using size- and location-adapted fractionation regimens to maximize the therapeutic ratio. Practical Radiation Oncology. 7(3). e233–e241. 8 indexed citations
7.
Mak, Winifred, et al.. (2016). Natural cycle IVF reduces the risk of low birthweight infants compared with conventional stimulated IVF. Human Reproduction. 31(4). 789–794. 39 indexed citations
8.
Gordon, John, Henrike Potthast, Jan Welink, et al.. (2015). Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons. European Journal of Clinical Pharmacology. 71(9). 1083–1089. 6 indexed citations
9.
García‐Arieta, Alfredo, John Gordon, & Henrike Potthast. (2015). On the Biopharmaceutics Classification System Biowaiver of Ibuprofen. Journal of Pharmaceutical Sciences. 104(8). 2429–2432. 6 indexed citations
11.
Gordon, John, Jan Welink, Henrike Potthast, et al.. (2014). Adjusted Indirect Treatment Comparison of the Bioavailability of WHO-Prequalified First-Line Generic Antituberculosis Medicines. Clinical Pharmacology & Therapeutics. 96(5). 580–588. 10 indexed citations
14.
García‐Arieta, Alfredo & John Gordon. (2012). Bioequivalence Requirements in the European Union: Critical Discussion. The AAPS Journal. 14(4). 738–748. 35 indexed citations
15.
Stea, Baldassarre & John Gordon. (2012). Clinically relevant biomarkers in targeted radiotherapy. Clinical & Experimental Metastasis. 29(7). 853–860. 5 indexed citations
16.
Torrado, Juan J., et al.. (2011). Investigation on the Possibility of Biowaivers for Ibuprofen. Journal of Pharmaceutical Sciences. 100(6). 2343–2349. 59 indexed citations
17.
Gordon, John, Katharine Hopkins, R. Brooke Jeffrey, & Linda C. Giudice. (1994). Adnexal torsion: color Doppler diagnosis and laparoscopic treatment. Fertility and Sterility. 61(2). 383–385. 42 indexed citations
18.
Thomson, Alison H., et al.. (1992). Bayesian Estimation of Streptomycin Pharmacokinetics. Therapeutic Drug Monitoring. 14(6). 522–524. 2 indexed citations
19.
Kay, Helen, et al.. (1992). Comparative analysis of normal and growth-retarded placentas with phosphorus nuclear magnetic resonance spectroscopy. American Journal of Obstetrics and Gynecology. 167(2). 548–553. 7 indexed citations
20.
Kay, Helen, John Gordon, Anthony A. Ribeiro, & Leonard D. Spicer. (1991). Phosphorus 31 magnetic resonance spectroscopy of human placenta and quantitation with perchloric acid extracts. American Journal of Obstetrics and Gynecology. 164(1). 80–87. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026